Comments on NCOIL Model Law on Drug Transparency Requirements AHIP Comments 12-4-18 PhRMA Comments 12-6-18 BCBSA – AHIP Comments 3-8-19 AMA Comments 3-14-19 BCBSA – AHIP Comments 7-10-19 PCMA Comment Letter – 7-12-19 AHIP Comment Letter – 11-26-19 AHIP Proposed Amendments 11-26-19 PCMA Comment Letter – 12-5-19 PhRMA Proposed Amendments – 12-9-19 BCBSA Comment Letter 12-11-19
